Skip to main content

Table 1 Baseline Characteristics

From: Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal

Characteristic

Results, mean ± SD (range) or n (% of patients)

Demographics

 

Women

23 (58%)

Age (years)

23 ± 7 (22–52)

Anthropometry

 

Body weight (kg)

56 ± 9 (37–77)

BMI

 

< 18.5

17 (46%)

18.5–24.9

18 (49%)

> 25

2 (5%)

HIV infection

 

Time since known HIV seropositivity (months)

12 ± 7 (5–30)

CDC clinical stage

 

B

19 (47%)

C

21 (53%)

CD4+ cell count (cells/mcL)

133 ± 92 (1–346)

< 50

9 (23%)

51–200

20 (50%)

> 200

11 (27%)

Viral load (log10 copies/mL)

5.5 ± 0.4 (4.6–5.9)

< 5 log

6 (15%)

≥ 5 log

34 (85%)

Blood cell count and blood chemistry

 

Hemoglobin concentration (g/dL)

11.5 ± 1.9 (7.7–15.4)

Neutrophil count (109/L)

2203 ± 1208 (775–7582)

Platelets (103/L)

256 ± 103 (56–493)

ALT (UI/L)

23 ± 15 (6–86)

Amylase (mmol/L)

90 ± 51 (24–262)

Triglycerides (mmol/L)

1.3 ± 0.4 (0.5–2.5)

Total cholesterol (mmol/L)

1.6 ± 0.5 (0.9–3.4)

  1. ALT = alanine amino transferase; BMI = body mass index; CDC = US Centers for Disease Control and Prevention; UI = Unité Internationale (International Units)